Does REVUMENIB Cause Differentiation syndrome? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Differentiation syndrome have been filed in association with REVUMENIB (Revuforj). This represents 4.3% of all adverse event reports for REVUMENIB.
16
Reports of Differentiation syndrome with REVUMENIB
4.3%
of all REVUMENIB reports
3
Deaths
4
Hospitalizations
How Dangerous Is Differentiation syndrome From REVUMENIB?
Of the 16 reports, 3 (18.8%) resulted in death, 4 (25.0%) required hospitalization.
Is Differentiation syndrome Listed in the Official Label?
Yes, Differentiation syndrome is listed as a known adverse reaction in the official FDA drug label for REVUMENIB.
What Other Side Effects Does REVUMENIB Cause?
Off label use (57)
Platelet count decreased (50)
Nausea (49)
Product dose omission issue (40)
Death (38)
Vomiting (26)
Fatigue (24)
Pyrexia (22)
Haemoglobin decreased (16)
White blood cell count decreased (16)
What Other Drugs Cause Differentiation syndrome?
TRETINOIN (251)
ARSENIC TRIOXIDE (180)
ENASIDENIB (102)
GILTERITINIB (80)
IVOSIDENIB (80)
AZACITIDINE (50)
HYDROXYUREA (41)
DEXAMETHASONE (38)
CYTARABINE (33)
PREDNISONE (25)
Which REVUMENIB Alternatives Have Lower Differentiation syndrome Risk?
REVUMENIB vs REYATAZ
REVUMENIB vs REZAFUNGIN
REVUMENIB vs RIBASPHERE
REVUMENIB vs RIBAVIRIN
REVUMENIB vs RIBOCICLIB